234 related articles for article (PubMed ID: 28507440)
1. Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment.
Shi Y; Jia R; Fan X
Onco Targets Ther; 2017; 10():2483-2489. PubMed ID: 28507440
[TBL] [Abstract][Full Text] [Related]
2. Periocular basal cell carcinoma - clinical perspectives.
Furdova A; Kapitanova K; Kollarova A; Sekac J
Oncol Rev; 2020 Feb; 14(1):420. PubMed ID: 32395200
[TBL] [Abstract][Full Text] [Related]
3. Vismodegib as an adjuvant treatment for periorbital basal cell carcinoma: a case report and review of literature.
Jabbehdari S; Veluvolu M; Kornhauser T; Jennings TA; Pemberton JD
Ann Transl Med; 2024 Jun; 12(3):54. PubMed ID: 38911557
[TBL] [Abstract][Full Text] [Related]
4. Primary basosquamous carcinoma of the lower eyelid with ocular invasion A case report.
Papadopoulos GO; Charitonidi E; Filippou N; Fanidou D; Filippou D; Scandalakis P
Ann Ital Chir; 2018 Mar; 7():. PubMed ID: 29626183
[TBL] [Abstract][Full Text] [Related]
5. Management of periocular basal cell carcinoma with modified en face frozen section controlled excision.
Wong VA; Marshall JA; Whitehead KJ; Williamson RM; Sullivan TJ
Ophthalmic Plast Reconstr Surg; 2002 Nov; 18(6):430-5. PubMed ID: 12439056
[TBL] [Abstract][Full Text] [Related]
6. Vismodegib and orbital excision for treating locally advanced basal cell carcinoma.
Hogarty DT; Dewhurst NG; Burt B
Int Med Case Rep J; 2018; 11():177-179. PubMed ID: 30104907
[TBL] [Abstract][Full Text] [Related]
7. Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.
Furdova A; Lukacko P
J Craniofac Surg; 2017 Jan; 28(1):e84-e87. PubMed ID: 27906855
[TBL] [Abstract][Full Text] [Related]
8. Vismodegib for periocular and orbital basal cell carcinoma.
Gill HS; Moscato EE; Chang AL; Soon S; Silkiss RZ
JAMA Ophthalmol; 2013 Dec; 131(12):1591-4. PubMed ID: 24136169
[TBL] [Abstract][Full Text] [Related]
9. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
Villalon-Lopez JS; Valle-Mejia CA; Patino-Lara A; Moreno-Perez BA; Munoz-Lopez JA; Alcantar-Andrade A
J Cancer Res Ther; 2006; 2(3):140-3. PubMed ID: 17998694
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of Basal Cell Carcinoma Treated with Surgical Excision and Histopathological Analysis with Frozen Section Technique with Complete Margin Control (CMC-FS): A 15-Year Experience of a Reference Center.
Di Maria A; Barone G; Ferraro V; Tredici C; Manara S; De Carlo C; Gaeta A; Confalonieri F
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568656
[TBL] [Abstract][Full Text] [Related]
11. Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
Sagiv O; Ding S; Ferrarotto R; Glisson B; Altan M; Johnson F; Elamin Y; Thakar SD; Nagarajan P; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2019; 35(4):350-353. PubMed ID: 30365473
[TBL] [Abstract][Full Text] [Related]
12. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
Sebastián Villalón-López J; Arturo Valle-Mejía C; Patiño-Lara A; Moreno-Pérez Bertha A; Alejo Muñoz-López J; Alcantar-Andrade A
J Cancer Res Ther; 2005; 1(3):132-5. PubMed ID: 17998643
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
14. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
16. Clinical, Histopathological and Therapeutical Analysis of Inferior Eyelid Basal Cell Carcinomas.
Totir M; Alexandrescu C; Pirvulescu R; Gradinaru S; Costache M
J Med Life; 2014; 7 Spec No. 4(Spec Iss 4):18-22. PubMed ID: 27057245
[TBL] [Abstract][Full Text] [Related]
17. Linear basal cell carcinoma: a distinct clinical entity in the periocular region.
Mavrikakis I; Malhotra R; Barlow R; Huilgol SC; Selva D
Ophthalmology; 2006 Feb; 113(2):338-42. PubMed ID: 16406534
[TBL] [Abstract][Full Text] [Related]
18. RECURRENT PERIOCULAR BASAL CELL CARCINOMA. CASE REPORT.
Prídavková Z; Bieliková A; Ferková N; Lysková D
Cesk Slov Oftalmol; 2021; 77(4):208-213. PubMed ID: 34507497
[TBL] [Abstract][Full Text] [Related]
19. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):624-30. PubMed ID: 15051192
[TBL] [Abstract][Full Text] [Related]
20. Destruction of the orbit and globe by recurrence of basal cell carcinoma.
Chew R
Optometry; 2007 Jul; 78(7):344-51. PubMed ID: 17601572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
